Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling.
Kohsaka S, Tada Y, Ando M, Nakaguro M, Shirai Y, Ueno T, Kojima S, Hirai H, Saigusa N, Kano S, Tsukahara K, Togashi T, Ozawa H, Kondo T, Okami K, Takahashi H, Kawakita D, Fushimi C, Suzuki T, Shimizu A, Okamoto I, Okada T, Sato Y, Imanishi Y, Watanabe Y, Sakai A, Ebisumoto K, Sato Y, Urano M, Honma Y, Yamazaki K, Ueki Y, Hanazawa T, Saito Y, Shimura T, Nagao T, Mano H. Kohsaka S, et al. Among authors: takahashi h. NPJ Precis Oncol. 2022 Nov 4;6(1):82. doi: 10.1038/s41698-022-00324-1. NPJ Precis Oncol. 2022. PMID: 36333410 Free PMC article.
Effects of Pembrolizumab in Recurrent/Metastatic Squamous Cell Head and Neck Carcinoma: A Multicenter Retrospective Study.
Okada T, Fushimi C, Matsuki T, Tokashiki K, Takahashi H, Okamoto I, Sato H, Kondo T, Hanyu K, Kishida T, Ito T, Yamashita G, Masubuchi T, Tada Y, Miura K, Omura GO, Yamashita T, Oridate N, Tsukahara K. Okada T, et al. Among authors: takahashi h. Anticancer Res. 2023 Jun;43(6):2717-2724. doi: 10.21873/anticanres.16438. Anticancer Res. 2023. PMID: 37247908
Brain metastases in patients with salivary duct carcinoma: A retrospective study.
Fushimi C, Takahashi H, Kawakita D, Kano S, Tsukahara K, Ozawa H, Okami K, Sakai A, Yamazaki K, Okada T, Hanazawa T, Sato Y, Imanishi Y, Shimizu A, Matsuki T, Nagao T, Tada Y. Fushimi C, et al. Among authors: takahashi h. Cancer Med. 2024 Mar;13(5):e7037. doi: 10.1002/cam4.7037. Cancer Med. 2024. PMID: 38477487 Free PMC article.
The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinoma.
Kajiwara M, Takahashi H, Nakaguro M, Kawakita D, Hirai H, Utsumi Y, Urano M, Sato Y, Tsukahara K, Kano S, Okami K, Ozawa H, Yamazaki K, Okada T, Shimizu A, Hanyu K, Sakai A, Yamauchi M, Sekimizu M, Hanazawa T, Saito Y, Ueki Y, Honma Y, Arai T, Iwaki S, Yamamura K, Imanishi Y, Sato Y, Tada Y, Nagao T; Multi-institutional Joint SDC Study Group in Japan. Kajiwara M, et al. Among authors: takahashi h. Virchows Arch. 2024 Sep;485(3):439-452. doi: 10.1007/s00428-024-03873-x. Epub 2024 Jul 23. Virchows Arch. 2024. PMID: 39042207
Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting.
Aizawa Y, Takada K, Aoyama J, Sano D, Yamanaka S, Seki M, Kuze Y, Ramilowski JA, Okuda R, Ueno Y, Nojima Y, Inayama Y, Hatakeyama H, Hatano T, Takahashi H, Nishimura G, Fujii S, Suzuki Y, Taniguchi H, Oridate N. Aizawa Y, et al. Among authors: takahashi h. Cell Oncol (Dordr). 2023 Apr;46(2):409-421. doi: 10.1007/s13402-022-00758-6. Epub 2022 Dec 20. Cell Oncol (Dordr). 2023. PMID: 36538240 Free PMC article.
NKX3.1 Helps Distinguish Hyalinizing Clear Cell Carcinoma From Other Clear Cell Salivary Gland Neoplasms.
Sakyo A, Ryo E, Nishino S, Kobayashi K, Yoshimoto S, Omura G, Fushimi C, Sakai T, Sakai A, Eguchi K, Takahashi H, Yokoyama K, Honma Y, Mori A, Kato H, Hatano T, Yoshida A, Matsumoto F, Yatabe Y, Mori T. Sakyo A, et al. Among authors: takahashi h. Lab Invest. 2024 Nov 29;105(3):102205. doi: 10.1016/j.labinv.2024.102205. Online ahead of print. Lab Invest. 2024. PMID: 39617100
A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia.
Hirayasu Y, Sato S, Takahashi H, Iida S, Shuto N, Yoshida S, Funatogawa T, Yamada T, Higuchi T. Hirayasu Y, et al. Among authors: takahashi h. BMC Psychiatry. 2016 Mar 15;16:66. doi: 10.1186/s12888-016-0778-9. BMC Psychiatry. 2016. PMID: 26980460 Free PMC article. Clinical Trial.
14,533 results
You have reached the last available page of results. Please see the User Guide for more information.